These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 9427029)
1. Detection of p53 protein overexpression and DNA ploidy analysis in colon cancer. Attallah AM; Elhak NG; Nasif WA; Tabll A; Ezzat F Hepatogastroenterology; 1997; 44(18):1595-601. PubMed ID: 9427029 [TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma. Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234 [TBL] [Abstract][Full Text] [Related]
3. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study. Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study. Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE; J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979 [TBL] [Abstract][Full Text] [Related]
5. Colon cancer: p53 expression and DNA ploidy. Their relation to proximal or distal tumor site. García-Hirschfeld García J; Blanes Berenguel A; Vicioso Recio L; Márquez Moreno A; Rubio Garrido J; Matilla Vicente A Rev Esp Enferm Dig; 1999 Jul; 91(7):481-8. PubMed ID: 10477366 [TBL] [Abstract][Full Text] [Related]
6. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues. Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389 [TBL] [Abstract][Full Text] [Related]
7. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers. Costa A; Marasca R; Valentinis B; Savarino M; Faranda A; Silvestrini R; Torelli G J Pathol; 1995 May; 176(1):45-53. PubMed ID: 7616356 [TBL] [Abstract][Full Text] [Related]
8. p53 expression and DNA ploidy pattern in Egyptian colorectal carcinoma. Zalata KR; Leech SH; Ming SC; Nasif WA; Nada NA; Mohamed IE; Atallah AM; Gad-el-Hak NA Hepatogastroenterology; 2002; 49(47):1225-9. PubMed ID: 12239910 [TBL] [Abstract][Full Text] [Related]
9. [Immunochemical evidence of a mutated p53 protein expressed in human colorectal adenocarcinoma]. Hammel PR; Beuvon FX; Salmon RJ; Remvikos Y Gastroenterol Clin Biol; 1991; 15(6-7):529-35. PubMed ID: 1916131 [TBL] [Abstract][Full Text] [Related]
10. Mutated p53 protein expression and proliferative activity in advanced gastric cancer. Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058 [TBL] [Abstract][Full Text] [Related]
11. [The relationships among DNA ploidy type determined by laser scanning cytometry, the overexpression of p53 protein and the numerical aberrations of chromosome 7 in bladder cancer]. Kawamura K; Ikeda R; Suzuki K Hinyokika Kiyo; 2000 Jun; 46(6):377-83. PubMed ID: 10934605 [TBL] [Abstract][Full Text] [Related]
12. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas. Sinicrope FA; Hart J; Hsu HA; Lemoine M; Michelassi F; Stephens LC Clin Cancer Res; 1999 Jul; 5(7):1793-804. PubMed ID: 10430084 [TBL] [Abstract][Full Text] [Related]
13. DNA in situ sensitivity to denaturation: a new parameter for flow cytometry of normal human colonic epithelium and colon carcinoma. Kunicka JE; Darzynkiewicz Z; Melamed MR Cancer Res; 1987 Aug; 47(15):3942-7. PubMed ID: 3607742 [TBL] [Abstract][Full Text] [Related]
14. [DNA ploidy pattern and p53 overexpression in gastric cancer]. Tomisaki S; Tatsuo O; Hisao O; Sakaguchi Y; Kusumoto T; Ohno S; Ichiyoshi Y; Maehara Y; Sugimachi K Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():115-7. PubMed ID: 7611772 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of p53 expression and DNA ploidy pattern in esophageal cancer]. Naitoh H; Kawaguchi A; Shibata J; Umeda T; Kodama M; Hattori T Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():110-4. PubMed ID: 7611771 [TBL] [Abstract][Full Text] [Related]
16. Determination of molecular marker expression can predict clinical outcome in colon carcinomas. Galizia G; Lieto E; Ferraraccio F; Orditura M; De Vita F; Castellano P; Imperatore V; Romano C; Ciardiello F; Agostini B; Pignatelli C Clin Cancer Res; 2004 May; 10(10):3490-9. PubMed ID: 15161706 [TBL] [Abstract][Full Text] [Related]
17. Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma. Xie D; Sham JS; Zeng WF; Lin HL; Bi J; Che LH; Hu L; Zeng YX; Guan XY Hum Pathol; 2005 Jul; 36(7):777-83. PubMed ID: 16084947 [TBL] [Abstract][Full Text] [Related]
18. Ploidy and proliferation patterns in colo-rectal adenocarcinomas related to Dukes' classification and to histopathological differentiation. A flow-cytometric DNA study. Tribukait B; Hammarberg C; Rubio C Acta Pathol Microbiol Immunol Scand A; 1983 Mar; 91(2):89-95. PubMed ID: 6846020 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma. Sinicrope FA; Hart J; Michelassi F; Lee JJ Clin Cancer Res; 1995 Oct; 1(10):1103-10. PubMed ID: 9815900 [TBL] [Abstract][Full Text] [Related]
20. DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma. Roa I; Villaseca M; Araya JC; Roa J; de Aretxabala X; Fuentealba P; Melo A Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):547-50. PubMed ID: 9232344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]